Abstract
Glycogen storage disease type 1a (GSD–1a) is caused by a deficiency in microsomal glucose–6–phosphatase (G6Pase), the key enzyme in glucose homeostasis. A G6Pase knockout mouse which mimics the pathophysiology of human GSD–1 a patients was created to understand the pathogenesis of this disorder, to delineate the mechanisms of G6Pase catalysis, and to develop future therapeutic approaches. By examining G6Pase in the liver and kidney, the primary gluconeogenic tissues, we demonstrate that glucose–6–P transport and hydrolysis are performed by separate proteins which are tightly coupled. We propose a modified translocase catalytic unit model for G6Pase catalysis
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nordlie, R.C. & Sukalski, K.A. Multifunctional glucose-6-phosphatase: a critical review, in The Enzymes of Biological Membranes (ed Martonosi, A. N.) 349–398 (Plenum Press, New York, 1985).
Chen, Y.-T. & Burchell, A. Glycogen storage diseases, in The Metabolic Basis of Inherited Diseases 7th edn. (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 935–965 (McGraw-Hill Inc., New York, 1994).
Moses, S.W. Pathophysiology and dietary treatment of the glycogen storage diseases. J. Pediat. Gastroenterol. Nutr. 11, 156–174 (1990).
Waddell, I.D. & Burchell, A. Transverse topology of glucose-6-phosphatase in rat hepatic endoplasmic reticulum. Biochem J. 275, 133–137 (1991).
Schulze, H.U., Nolte, B. & Kannler, R. Evidence for changes in the conformational status of rat liver microsomal glucose-6-phosphate: phosphohydrolase during detergent-dependent membrane modification. J. Biol. Chem. 261, 16571–16578 (1986).
St-Denis, J.-F., Berteloot, A., Vidal, H., Annabi, B. & van de Werve, G. Glucose transport and glucose-6-phosphate hydrolysis in intact rat liver microsomes. J. Biol. Chem. 270, 21092–21097 (1995).
Arion, W.J., Lange, A.J., Walls, H.E. & Ballas, L.M. Evidence of the participation of independent translocases for phosphate and glucose-6-phosphate in the microsomal glucose-6-phosphatase system. J. Biol. Chem. 255, 10396–10406 (1980).
Burchell, A. Molecular pathology of glucose-6-phosphatase. FASEB J. 4, 2978–2988 (1990).
Lange, A.J., Arion, W.J. & Beaudet, A.L. Type 1b glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system. J. Biol. Chem. 255, 8381–8384 (1980).
Igarashi, Y., Kato, S., Narisawa, K. & Tada, K. A direct evidence for defect in glucose-6-phosphatase transport system in hepatic microsomal membrane of glycogen storage disease type 1 b. Biochem. Biophys. Res. Commun. 119, 593–597 (1984).
Nordlie, R.C., Sukalski, K.A., Munoz, J.M. & Baldwin, J.J. Type 1 c, a novel glycogenosis. J. Biol. Chem. 258, 9739–9744 (1983).
Waddell, I.D., Hume, R. & Burchell, A. A direct method for the diagnosis of human hepatic type 1 b and type 1 c glycogen-storage disease.Clin. Sci. 76, 573–579 (1989).
Shelly, L.L. et al. Isolation of the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1 a. J. Biol. Chem. 268, 21482–21485 (1993).
Lei, K.-J., Shelly, L.L., Pan, C.-J., Sidbury, J.B. & Chou, J.Y. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1 a. Science 262, 580–583 (1993).
Lei, K.-J. et al. Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am. J. Hum.Genet. 57, 766–771 (1995).
Lei, K.-J. et al. Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease type 1a and 1aSP but not 1b and 1c. J. Clin. Invest. 95, 234–240 (1995).
Tybulewicz, V.L.J., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153–1163 (1991).
Love, P.E. et al. T cell development in mice that lack the q chain of the T cell antigen receptor complex. Science 261, 918–921 (1993).
Mansour, S.L., Thomas, K.R. & Capecchi, M.R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348–352 (1988).
Chayen, J. & Bitensky, L. Analysis of chemical components of cells and tissues, in Practical Histochemistry. 45–134 (John Wiley & Sons, New York, 1991).
McAdams, A.J., Hug, G. & Bove, K.E. Glycogen storage disease types I to X: Criteria for morphologic diagnosis. Hum. Pathol. 5, 463–487 (1974).
Singh, J., Nordlie, R.C. & Jorgenson, R.A. Vanadate: a potent inhibitor of multifuntional glucose-6-phosphatase. Biochim. Biophys. Acta 678, 477–482 (1981).
Chen, Y.-T., Coleman, R.A., Scheiman, J.I., Kolbeck, P.C. & Sidbury, J.B. Renal disease in type I glycogen storage disease. N. Engl. J. Med. 318, 7–11 (1988).
Emmett, M. & Narins, R.G. Renal transplantation in type 1 glycogenosis: failure to improve glucose metabolism. JAMA 239, 1642–1644 (1978).
Chen, Y.-T. & Scheinman, J.I. Hyperglycaemia associated with lactic acidaemia in a renal allograft recipient with type 1 glycogen storage disease. J. Inher. Metab. Dis. 14, 80–86 (1991).
Malatack, J.J. et al. Liver transplantation for type 1 glycogen storage disease. Lancet 1, 1073–1075 (1983).
Kirschner, B.S., Baker, A.L. & Thorp, F.K. Growth in adulthood after liver transplantation for glycogen storage disease type 1. Gastroenterol. 101, 238–241 (1991).
Burchell, A., Hume, R. & Burchell, B. A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system.Clim. Chim. Acta 173, 183–192 (1988).
Hers, H.G. in Advances in Metabolic Disorders. Vol 1 (eds Levine, R., & Luft, L) 1–44 (Academic Press, London, 1964).
Teutsch, H.F. Chemomorphology of liver parenchyma: Qualitative histochemical distribution patterns and quantitative sinusoidal profiles of G6Pase, G6PDH and malic enzyme activity and of glycogen content, in Progress in Histochemistry and Cytochemistry . Vol. 14 (Laupp & Gobel, New York, 1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lei, KJ., Chen, H., Pan, CJ. et al. Glucose–6–phosphatase dependent substrate transport in the glycogen storage disease type–1a mouse. Nat Genet 13, 203–209 (1996). https://doi.org/10.1038/ng0696-203
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0696-203
This article is cited by
-
Amnio acid substitution at position 298 of human glucose-6 phosphatase-α significantly impacts its stability in mammalian cells
Amino Acids (2023)
-
Studies on glycogen storage disease type 1a animal models: a brief perspective
Transgenic Research (2022)
-
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia
Orphanet Journal of Rare Diseases (2020)
-
Molecular biology and gene therapy for glycogen storage disease type Ib
Journal of Inherited Metabolic Disease (2018)
-
Long‐term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia
Journal of Inherited Metabolic Disease (2018)